Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

CALM Study: Cardiomems Assisted Lvad Management

NCT: NCT07096544 · RECRUITING

NCT IDNCT07096544
StatusRECRUITING
Start Date2026-05-08
Completion2027-09-01
SponsorBaylor Research Institute (OTHER)
First posted
Last updated

Brief Summary

This prospective, open label, randomized, single-center pilot clinical trial will determine if the rate of heart failure related (HFR) hospitalizations is less in LVAD patients whose PAP is monitored with the CardioMEMS device vs the control patients receiving standard of care treatment.

Frequently Asked Questions

What is CALM Study: Cardiomems Assisted Lvad Management?

CALM Study: Cardiomems Assisted Lvad Management is a clinical trial registered under NCT07096544. Current status: RECRUITING.

What is the status of NCT07096544?

The current status of NCT07096544 (CALM Study: Cardiomems Assisted Lvad Management) is: RECRUITING.

When did CALM Study: Cardiomems Assisted Lvad Management start?

CALM Study: Cardiomems Assisted Lvad Management started on 2026-05-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑